Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma

The absolute peripheral blood lymphocyte count at diagnosis is known to be a strong prognostic factor in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), but it remains unclear as to which peripheral blood...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Cancer J
Main Authors: Kusano, Y, Yokoyama, M, Terui, Y, Nishimura, N, Mishima, Y, Ueda, K, Tsuyama, N, Hirofumi, Y, Takahashi, A, Inoue, N, Takeuchi, K, Hatake, K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436080/
https://ncbi.nlm.nih.gov/pubmed/28430176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2017.37
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados